Clinical Trial: NCT05366478
A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors
Status:
RECRUITINGPhase:
Phase 1| Lead Sponsor: | Suzhou BlueHorse Therapeutics Co., Ltd. |
| Information Provided By: | Suzhou BlueHorse Therapeutics Co., Ltd. |
| Last Update Posted: | 2022-08-02 |
Study Overview
Brief Summary
This is a single-arm, open-label, exploratory study to evaluate safety and efficacy of LM103 Injection in patients with advanced solid tumors. The purpose of this study is to evaluate the safety and tolerability, antitumor activity and immunoreactivity.
Official Title
A Single-Arm, Open-Label, Exploratory Study to Evaluate Safety and Efficacy of LM103 Injection in the Treatment of Advanced Solid Tumors
Conditions
Melanoma, Non Small Cell Lung Cancer, Cervical Carcinoma
Intervention / Treatment
- Drug: Autologous tumor infiltrating lymphocytes (TILs)
Other Study ID Numbers
- TIL-2021001
Start Date (Actual)
2022-05-30
Primary Completion Date (Estimated)
2024-05-30
Study Completion Date (Estimated)
2029-05-30
Enrollment (Estimated)
15
Study Type
Interventional
Phase
Phase 1
| Lead Sponsor: | Suzhou BlueHorse Therapeutics Co., Ltd. |
| Information Provided By: | Suzhou BlueHorse Therapeutics Co., Ltd. |
| Last Update Posted: | 2022-08-02 |
Study Overview
Brief Summary
This is a single-arm, open-label, exploratory study to evaluate safety and efficacy of LM103 Injection in patients with advanced solid tumors. The purpose of this study is to evaluate the safety and tolerability, antitumor activity and immunoreactivity.
Official Title
A Single-Arm, Open-Label, Exploratory Study to Evaluate Safety and Efficacy of LM103 Injection in the Treatment of Advanced Solid Tumors
Conditions
Melanoma, Non Small Cell Lung Cancer, Cervical Carcinoma
Intervention / Treatment
- Drug: Autologous tumor infiltrating lymphocytes (TILs)
Other Study ID Numbers
- TIL-2021001
Start Date (Actual)
2022-05-30
Primary Completion Date (Estimated)
2024-05-30
Study Completion Date (Estimated)
2029-05-30
Enrollment (Estimated)
15
Study Type
Interventional
Phase
Phase 1